Damora Therapeutics (DMRA) traded down -2.86 % during a 24 hours period ending at 01:04 AM Central Europe on Tuesday 27th. One Damora Therapeutics stock can currently be bought for about USD 21.26 on popular exchanges. Current supply of Damora Therapeutics stocks is 61.6 mn. Damora Therapeutics has a current market capitalization of USD 1.3 bn and approximately USD 7.6 mn worth of Damora Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Damora Therapeutics has traded 4.05 % up. Simple moving average of last 200 days is at USD 25.67. The highest price of past 52 weeks was recorded at USD 38.32 on 12/26/2025. 52 weeks low was at USD 4.95 on 11/07/2025.
Here is how related stocks have performed in the past 24 hours:
Gcs (4991.TW) traded flat 0 % and now trades at TWD 415. Current market capitalisation for Gcs is TWD 50.3 bn. Gcs has a current price to earnings ratio of 126.57.
Sprinklr (CXM) traded flat 0 % and now trades at USD 6.71. Sprinklr has a market capitalisation of USD 1.6 bn. Sprinklr has a current price to earnings ratio of 69.8.
Energizer (ENR) traded down -3.67 % and now trades at USD 22.29. Energizer has a market capitalisation of USD 1.6 bn. Energizer has a current price to earnings ratio of 19.18.
Ani (ANIP) traded down -1.55 % and now trades at USD 72.6. Ani has a market capitalisation of USD 1.6 bn. Ani has a current price to earnings ratio of 16.
Ultragenyx Pharmaceutical (RARE) traded down -1.88 % and now trades at USD 16.08. Current market capitalisation for Ultragenyx Pharmaceutical is USD 1.5 bn.
About Damora Therapeutics
Galecto, Inc. is a clinical stage biotechnology company based in Copenhagen, Denmark. The company specializes in developing small molecules for the treatment of severe diseases such as fibrosis, cancer, and inflammation. Gallecto serves customers globally and can be accessed through their website at www.galecto.com . The company’s stock is traded on the Nasdaq.